It should be noted that in the NICE‐SUGAR study, the control group was also treated with insulin to keep glycemic levels between 140 and 180 mg/dl, instead of the uncontrolled hyperglycemia (up to 215 mg/dl) in the first studies (Gunst & Van den Berghe, 2016). The gene discussed is INS; the disease is Hyperglycemia.